BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34863240)

  • 1. Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II.
    Yee KS; Wu Y; Harrington M; Waisbren SE
    Orphanet J Rare Dis; 2021 Dec; 16(1):501. PubMed ID: 34863240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.
    Muenzer J; Burton BK; Amartino HM; Harmatz PR; Gutiérrez-Solana LG; Ruiz-Garcia M; Wu Y; Merberg D; Alexanderian D; Jones SA
    Orphanet J Rare Dis; 2023 Nov; 18(1):357. PubMed ID: 37974184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.
    Yee KS; Alexanderian D; Merberg D; Natarajan M; Wang S; Wu Y; Whiteman DAH
    Mol Genet Metab; 2023 Nov; 140(3):107652. PubMed ID: 37506513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study.
    Muenzer J; Burton BK; Harmatz P; Gutiérrez-Solana LG; Ruiz-Garcia M; Jones SA; Guffon N; Inbar-Feigenberg M; Bratkovic D; Hale M; Wu Y; Yee KS; Whiteman DAH; Alexanderian D;
    Mol Genet Metab; 2022; 137(1-2):127-139. PubMed ID: 36027721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A post hoc analysis of Projected Retained Ability Scores (PRAS) for the longitudinal assessment of cognitive functioning in patients with neuronopathic mucopolysaccharidosis II receiving intrathecal idursulfase-IT.
    Yee KS; Chirila C; Davenport E; Mladsi D; Barnett C; Kronenberger WG
    Orphanet J Rare Dis; 2023 Nov; 18(1):343. PubMed ID: 37915038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
    Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
    Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II.
    Muenzer J; Burton BK; Harmatz P; Gutiérrez-Solana LG; Ruiz-Garcia M; Jones SA; Guffon N; Inbar-Feigenberg M; Bratkovic D; Hale M; Wu Y; Yee KS; Whiteman DAH; Alexanderian D;
    Mol Genet Metab; 2022; 137(1-2):92-103. PubMed ID: 35961250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
    Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
    Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.
    Shapiro EG; Eisengart JB; Whiteman D; Whitley CB
    Mol Genet Metab; 2024 Feb; 141(2):108110. PubMed ID: 38151384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal trajectories of intellectual and adaptive functioning in adolescents and adults with Williams syndrome.
    Fisher MH; Lense MD; Dykens EM
    J Intellect Disabil Res; 2016 Oct; 60(10):920-32. PubMed ID: 27273269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim results of adaptive functioning and neurodevelopment in BUTTERFLY - An observational study of children and adolescents with Dravet syndrome.
    Sullivan J; Wirrell E; Knupp KG; Chen D; Zafar M; Flamini R; Stutely J; Brathwaite C; Ventola P; Avendaño J; Parkerson KA; Wyant N; Ticho B
    Epilepsy Behav; 2022 Dec; 137(Pt A):108955. PubMed ID: 36332561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI).
    Salomon-Estebanez M; Mohamed Z; Michaelidou M; Collins H; Rigby L; Skae M; Padidela R; Rust S; Dunne M; Cosgrove K; Banerjee I; Nicholson J
    Orphanet J Rare Dis; 2017 May; 12(1):96. PubMed ID: 28532504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Outcomes of Children 1 Year After Pediatric Cardiac Arrest: Secondary Analysis of 2 Randomized Clinical Trials.
    Slomine BS; Silverstein FS; Christensen JR; Page K; Holubkov R; Dean JM; Moler FW
    JAMA Neurol; 2018 Dec; 75(12):1502-1510. PubMed ID: 30242322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobehavioral Outcomes in Children After Out-of-Hospital Cardiac Arrest.
    Slomine BS; Silverstein FS; Christensen JR; Holubkov R; Page K; Dean JM; Moler FW;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26940987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).
    Mattera M; Vernon MK; Raluy-Callado M; Mikl J
    Health Qual Life Outcomes; 2018 Nov; 16(1):209. PubMed ID: 30409228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobehavioural outcomes in children after In-Hospital cardiac arrest.
    Slomine BS; Silverstein FS; Christensen JR; Holubkov R; Telford R; Dean JM; Moler FW;
    Resuscitation; 2018 Mar; 124():80-89. PubMed ID: 29305927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonverbal Cognitive Skills in Children With Aicardi Goutières Syndrome.
    Gavazzi F; Vaia Y; Woidill S; Formanowski B; Peixoto de Barcelos I; Sevagamoorthy A; Modesti NB; Charlton L; Cusack SV; Vincent A; D'Aiello R; Jawad A; Galli J; Varesio C; Fazzi E; Orcesi S; Glanzman AM; Lorch S; DeMauro SB; Guez-Barber D; Waldman AT; Vanderver A; Adang LA
    Neurology; 2024 Jul; 103(1):e209541. PubMed ID: 38857477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.
    Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM
    Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma.
    Netson KL; Conklin HM; Wu S; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1301-6. PubMed ID: 23245284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Arrest Outcomes in Children With Preexisting Neurobehavioral Impairment.
    Christensen JR; Slomine BS; Silverstein FS; Page K; Holubkov R; Dean JM; Moler FW;
    Pediatr Crit Care Med; 2019 Jun; 20(6):510-517. PubMed ID: 30807545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.